Safety of smoking cessation drugs for mentally ill patients.
Centre for Addiction and Mental Health, Department of Pharmacology and Toxicology, Faculty of Medicine University of Toronto, 175 College Street, ON MST 1P7 Toronto, Canada. Electronic address: laurie.zawertailo@camh.ca.
Laurie
L
Zawertailo
D016642:Bupropion / Q000008:administration & dosage*; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D018722:Nicotinic Agonists / Q000008:administration & dosage*; D000074606:Smoking Prevention; D061485:Tobacco Use Cessation Devices; D000068580:Varenicline / Q000008:administration & dosage*
D018765:Dopamine Uptake Inhibitors; D018722:Nicotinic Agonists; D016642:Bupropion; D000068580:Varenicline